Arcus Biosciences (RCUS) Other financing activities (2018 - 2026)

Arcus Biosciences' Other financing activities history runs 9 years deep, the most recent figure standing at $3.0 million for Q1 2026.

• On a quarterly basis, Other financing activities changed N/A year-over-year to $3.0 million in Q1 2026; TTM through Mar 2026 was $13.0 million, a 62.5% increase from a year earlier, with the FY2025 full-year figure at $10.0 million, up 11.11% from the prior year.
• Other financing activities slipped to $3.0 million in Q1 2026 per RCUS's latest filing, from $7.0 million in the prior quarter.
• Across five years, Other financing activities topped out at $18.0 million in Q4 2022 and bottomed at -$9.0 million in Q3 2022.
• The 5-year median for Other financing activities is $3.0 million (2023), against an average of $3.5 million.
• Biggest YoY gain for Other financing activities was 4190.91% in 2022; the steepest drop was 782.85% in 2022.
• Year by year, Other financing activities stood at $18.0 million in 2022, then tumbled by 83.33% to $3.0 million in 2023, then changed by 0.0% to $3.0 million in 2024, then jumped by 133.33% to $7.0 million in 2025, then plunged by 57.14% to $3.0 million in 2026.
• Per Business Quant, the three latest RCUS Other financing activities figures stand at $3.0 million (Q1 2026), $7.0 million (Q4 2025), and $3.0 million (Q2 2025).